Patrick Aisher

Patrick Aisher is a seasoned investor with years of experience in Life Science, Finance, and Technology sectors. He is the founder shareholder in the Central European Biotech Incubator & Accelerator and a Partner/Founder/Director in various Life Science and Digital Technology Investment Companies worldwide. Patrick's expertise and education span across various financial and investment fields, including Trust Management, Trust Law, Entrepreneurial Finance, Regulatory, and Business Administration.

Throughout his career, Patrick has been instrumental in various investment ventures and companies, including TruFin plc, PreComb Therapeutics AG, Corlieve Therapeutics, and Araris Biotech AG, to mention a few. Besides, he has held strategic leadership positions in many others, including Orchestra BioMed, Inc., EYEVENSYS, and Algonist Biotechnologies.

Patrick has an extensive academic background, including a Master of Business Administration (MBA) from Heriot-Watt University, a Swiss Advanced Certificate in Trust Management Program, and a BBA in Business Administration and Economics Programme from Schiller International University, among others.

Currently, Patrick is managing Kinled Holding, a Hong Kong-based company with offices in Switzerland, the UK, and Austria. The company holds direct investments in over 50 innovative businesses in Life Science, Finance, and Technology sectors. Kinled Holding is managed exclusively for the benefit of a private family office.